International Conference on Glycobiology (Glycobiology Conference 2017) will be held in Houston, USA in September 21-22, 2017. The conference will bring together biochemists, scientists, molecular biologists, industry experts, delegates, sponsors and exhibitors from all around the world to the splendid city of Houston, USA. The conference focuses on the theme "New innovations in the era of glycobiology research".
Glycobiology is a vast subject that includes the structure, biosynthesis, and biology of saccharides. It is the booming field in the area of research related to biomolecules which includes the study of metabolism and pathways, the prediction of the structure of biomolecules and many others etc.
Why to attend???
With members from all around the world have focused on learning more about biomolecules and Glycobiology, this is your best chance to meet the participants in the arena of Glycobiology, share information, meet current and potential scientists and receive name recognition in this 2-day premier event.
Scientists and Researchers
Biochemistry Associations and Societies
Pulsus Group Inc. is an internationally renowned peer-review publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada and Hyderabad, India. Pulsus acquired Andrew John Publishing and open accessjournals.com to expand its Open Access Publishing through its 50+ journals in association with 20+ International medical and scientific societies.
Pulsus through its cmesociety.com is been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies and organizations from different countries through international CME/CPD accredited conferences and meetings.
Glycobiology is the study of the structure, biosynthesis and biology of saccharides that are widely distributed in nature. Sugars or saccharides are essential components of all living things and aspects of the various roles they play in biology and are researched in various medical, biochemical and biotechnological fields. The study of glycan structures is also complicated by the lack of a direct template for their biosynthesis, contrary to the case with proteins where their amino acid sequence is determined by their corresponding gene.
The natural ligands for most lectins are typically complex glycoconjugates that carry clustered arrays of the cognate carbohydrate or unique glycan structures, thus cooperating with clustered lectin-binding sites to generate high-avidity binding, which is further enhanced by mass transport effects (high local concentrations of ligands). Mass spectrometry based glycomic quantification was performed to look for alterations in N-glycan profiles between normal and diabetic plasma samples. Fucosylated N-glycans and intersected N-glycans were found to be up-regulated in diabetes with statistical significance.
Glyco-epitope diversity enhances the role of glycans in the group of debilitating and life-shortening disorders known as congenital muscular dystrophy, or CMD. Glycosylation is a critical function of the biosynthetic-secretory pathway in the endoplasmic reticulum (ER) and Golgi apparatus. Glycosylation increases the diversity of the proteome to a level unmatched by any other post-translational modification. Glycosidases catalyse the hydrolysis of glycosidic bonds to remove sugars from proteins.
Mass spectrometry (MS) is an analytical technique that ionizes chemical species and sorts the ions based on their mass-to-charge ratio. A mass spectrum is a plot of the ion signal as a function of the mass-to-charge ratio. These spectra are used to determine the elemental or isotopic signature of a sample, the masses of particles and of molecules, and to elucidate the chemical structures of molecules, such as peptides and other chemical compounds.
Glycobiology and Medicine
Drugs already on the market such as heparin, erythropoietin and a few anti-flu drugs have proven effective and highlight the importance of glycans as a new class of drug. Additionally, the search for new anti-cancer drugs is opening up new possibilities in glycobiology. Anti-cancer drugs with new and varied action mechanisms together with anti-inflammatory and anti-infection drugs are today undergoing clinical trials. They may alleviate or complete current therapies. Although these glycans are molecules that are difficult to synthesize in a reproducible way owing to their complex structure and this new field of research is highly encouraging for the future.
Glycobiology and Proteomics
Glycans are secondary gene products and therefore are generated by the coordinated action of many enzymes in the subcellular compartments of a cell. Multiple Reaction Monitoring (MRM) is a mass spectrometry-based technique that has recently been used for site-specific glycosylation profiling. Although MRM has been used extensively in metabolomics and proteomics, its high sensitivity and linear response over a wide dynamic range make it especially suited for glycan biomarker research and discovery.
Glycoconjugates and Glycomics
Glycomics analogous to genomics and proteomics is the systematic study of all the glycan structures of a given cell type or organism and is a subset of glycobiology. Sugars may be linked to other types of biological molecule to form glycoconjugates. The enzymatic process of glycosylation creates sugars or saccharides linked to themselves and to other molecules by the glycosidic bond, thereby producing glycans. Glycoproteins, proteoglycans and glycolipids are the most abundant glycoconjugates found in mammalian cells. Glycoconjugates have been shown to be important in cell-cell interactions due to the presence on the cell surface of various glycan binding receptors in addition to the glycoconjugates themselves.
Glycans in vaccine development
Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.
Glycobiology and Glycochemistry
Glycans can be found attached to the proteins as in glycoproteins and proteoglycans. Carbohydrates have long been underappreciated by the scientific community and many scientists approach the complex structures and elaborate nomenclature of carbohydrates with trepidation. Like amino acids and nucleic acids, sugars are abundant in nature many natural products contain oligosaccharides that are vital for their biological activity and carbohydrates have key roles in a broad range of biological processes including signal transduction and immune responses.
Glycosciences and Monosaccharides
Glycoscience has become a vibrant, expanding and important extension of modern molecular biology and medicine. The wide complexity of glycosylated structures is only paralleled to their utility. Discovering carbohydrate antigens as tumour markers or even abnormal glycation pathways in metabolic diseases such as diabetes precluded the importance of the expansion of Glycoscience in a near future, as a way of disclosing new biomarkers and therapeutic targets in disease. The ultimate goal is to build research capacity on Glycosciences and seed ground to translate emerging discoveries in Glycosciences into new diagnostics and clinical applications.
Glycobiology and Protein Biochemistry
Proteins are a primary constituent of living things and one of the chief classes of molecules studied in biochemistry. Proteins provide most of the molecular machinery of cells. Many are enzymes or subunits of enzymes. Other proteins play structural or mechanical roles, such as those that form the struts and joints of the cytoskeleton. The study of proteins through protein biochemistry and enzymology encompasses many fields of biology, including molecular biology, cell biology, pharmaceutical research and development, food science, plant biology and more.
Recent Advances in Glycobiology
Glycobiology is one of the vast expanding fields. In the course of time many advances have taken place and huge number of solved structures has amplified rapidly. The field of drug design and molecular modelling has been advanced. Functional annotations are another field where progressions are being seen. Alterations in order to improve the effectiveness of prevailing tools can also be noted. Many remarkable advances can be seen in the areas of imaging technologies and advancement of hybrid methods to understand the structure and function of proteins.
Glycobiology Market Global Forecast to 2019: The Glycobiology market will reach $928.11 million by 2019, growing at a CAGR of 12.62% during the forecast period (2014–2019). This report segment the global Glycobiology market by application, end users, products, and geographies. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the Glycobiology enzymes, instruments, kits, and reagents market. A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global Glycobiology enzymes.
Medical News Today is the largest independent medical and health news site on the web - with over 8,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted disease/condition and general health campaigns.
PMR is a market research and consulting company active within over 25 countries of Central and Eastern Europe. Since 1995 we have assisted more than 500 global corporations and many other regional companies to continuously increase their market share, successfully enter new territories and optimise costs. We specialise in construction, retail, pharmaceuticals, healthcare, IT and telecommunications. However, our experience extends to many other industries. Our 100 in-house professionals fluently speak together more than 15 languages. In addition to our tailored research and business consulting projects we also publish annually over 150 ready sector reports and market intelligence services.
Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within Technology Networks.com.
Medgenera-A Biopreneurs News Network is a globally leading digital media platform for business, finance and innovations in biotech, pharma, chemistry and healthcare industries. Visit this platform for most updated coverage of research, entrepreneurship, and health and wellness news, jobs and events updates, experts insights/commentaries, progressive reviews on cutting-edge research and trending topics in bio-entrepreneurship and business, CEOs and bio-entrepreneurs interviews etc.
Biology and Medicine is a peer-reviewed, online journal, efficiently publishing original and relevant articles in thrust areas of research.
Bentham Science Publishers is rendering a vital service in the quality publication that publishes over 100 peer-reviewed print and online scientific, technical and medical journals. These titles are indexed in recognized indexing agencies, such as Science Citation Index®, Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE etc. Some of the high impact titles which enjoy a wide reach and distribution are Current Gene Therapy (Impact Factor 4.906), Current Alzheimer Research (Impact Factor 3.796), Current Medicinal Chemistry (Impact Factor 3.715), and other popular titles. Bentham has an extensive library of eBooks in the areas of science, technology, medicine, social sciences and humanities. Bentham eBooks publishes monographs, handbooks, conference proceedings, textbooks, review volumes, biographies and autobiographies.